gallstones/rasvumus

Link salvestatakse lõikelauale

Artiklid Kliinilistes uuringutes Patendid

Valige sortimise tüüp

12 tulemused

Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

The contents of the text file named SYPA-003_C04US_SeqList_ST25.txt, which was created on Jun. 17, 2015 and is 107 KB in size, are hereby incorporated by reference in their entirety. FIELD OF THE INVENTION The present invention relates to the therapeutic use of guanylate cyclase C (GC-C) agonists as

Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

FIELD OF THE INVENTION The present invention relates to the therapeutic use of guanylate cyclase C (GC-C) agonists as for reducing absorption of fat, triglycerides, bile acids and cholesterol. The agonists may be used either alone or in combination with inhibitors of cholesterol biosynthesis in the

Treatment of gallstones

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

THIS INVENTION RELATES TO A METHOD OF TREATING GALLSTONES. According to the present invention there is provided a method of treating gallstones, in which a therapeutically effective amount of a compound of formula I ##STR2## including enantiomers and pharmaceutically acceptable salts thereof, in

Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

TECHNICAL FIELD The present invention relates to novel phenylaminoalkyl-carboxylic acid derivatives and pharmaceutically acceptable salts thereof which are useful as medicaments. BACKGROUND ART It is known that three subtypes of sympathomimetic .beta.-adrenoceptors, which have been classified as

Indazole compounds

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

TECHNICAL FIELD The present invention relates to indazole compounds having a .beta.3 adrenergic receptor agonist activity, a pharmaceutical composition containing the same, and uses of the compounds and the composition. BACKGROUND ART Noradrenaline and adrenaline are known to exhibit a variety of

Use of ivermectin and derivatives thereof

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a National Stage filing under 35 U.S.C. .sctn. 371 of International Patent Application No. PCT/CN2013/077796, filed on Jun. 24, 2013, entitled "Use of Ivermectin and Derivatives Thereof", which claims the benefit of and priority to Chinese

2-methylpropionic acid derivatives and pharmaceutical compositions comprising the same

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

TECHNICAL FIELD The present invention relates to novel 2-methylpropionic acid derivatives and pharmaceutically acceptable salts thereof which are useful as medicaments. BACKGROUND ART It is known that three subtypes of sympathetic .beta.-adrenoceptors, which have been classified as .beta..sub.1,

2-Methylpropionic acid derivatives and medicinal compositions containing the same

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

Phenoxyacetic acid derivatives and medicinal compositions containing the same

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

TECHNICAL FIELD The present invention relates to novel phenoxyacetic acid derivatives and pharmaceutically acceptable salts thereof which are useful as medicaments. BACKGROUND ART It is known that three subtypes of sympathetic .beta.-adrenoceptor, which have been classified as .beta..sub.1,

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

DESCRIPTION This invention relates to the use of nucleic acid sequences of the MAP kinase-interacting kinase (Mnk) gene family and amino acid sequences encoded thereby, and to the use of these sequences or effectors of Mnk nucleic acids or polypeptides, particularly Mnk kinase inhibitors and

Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to PCT Patent Application No. PCT/EP02/03540 filed Mar. 28, 2002 and European Patent Applications No. EP01 108 315.1 filed Apr. 2, 2001 and EP01 113 419.4 filed Jun. 1, 2001. DESCRIPTION This invention relates to the use of

Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis

Ainult registreeritud kasutajad saavad artikleid tõlkida

Logi sisse

DESCRIPTION This invention relates to the use of nucleic acid and amino acid sequences of protein disulfide isomerase and ABC transporter homologous proteins, and to the use of these sequences in the diagnosis, study, prevention, and treatment of diseases and disorders related to body-weight

Liitu meie
facebooki lehega

Herbal & Natural Medicine

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

Töötab 55 keeles
Taimsed ravimid, mida toetab teadus
Maitsetaimede äratundmine pildi järgi
Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
Lugege oma otsinguga seotud teaduspublikatsioone
Otsige ravimtaimi nende mõju järgi
Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel